ABBV vs SYK
By Alex · Tickerpine
AbbVie Inc. vs Stryker Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | SYK |
|---|---|---|
| Price | $265.79 | $330.59 |
| Market cap | $469.68B | $126.81B |
| P/E ratio | 74.7 | 34.3 |
| ROE | — | 16.51% |
| Profit margin | 9.80% | 14.43% |
| Revenue growth | 10.20% | 9.40% |
| Dividend yield | 2.62% | 1.07% |
| Beta | 0.28 | 0.77 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs SYK in plain English
- ABBV is the bigger company — about 3.7× the market cap of SYK.
- SYK is cheaper on earnings (P/E 34.3 vs 74.7).
- ABBV is growing revenue faster (10% vs 9%).
- ABBV has the higher dividend yield (2.62% vs 1.07%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
SYK return calculator
See what $1,000 in Stryker Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.